MHRA announces AI Airlock expansion and joins global health AI regulatory network
The Medicines and Healthcare products Regulatory Agency (MHRA) has opened applications for an expanded AI Airlock programme following last year's pilot. The agency has also become the first founding member of Health AI's new global network of health regulators, aimed at sharing early warnings on safety and shaping international standards. Additionally, MHRA's Centre of Excellence for Regulatory Science and Innovation (CERSI) partner RADIANT has launched an Innovator Support Programme, while the agency prepares to publish Good Machine Learning Practice guidance to align with international principles. These initiatives form part of MHRA's strategy to balance innovation with patient safety in AI medical devices.